BACKGROUND: Serum citrulline concentration is used as a biomarker of enterocyte mass and enteral tolerance, and low serum concentrations are correlated with bacteremia in immunosuppressed adults undergoing hematopoietic stem cell transplant. The authors sought to determine if citrulline was associated with the development of catheter-related bloodstream infections (CRBSIs) in children with intestinal failure. METHODS: Data were reviewed from 66 children treated in a multidisciplinary intestinal rehabilitation program, who had serum concentration citrulline measured between January 2007 and August 2009. All patients had a diagnosis of intestinal failure requiring parenteral nutrition (PN) support. Exclusion criteria included central venous catheter in situ <30 days, creatinine clearance <20 mL/minute, or a history of organ transplant/immunosuppression. RESULTS: A total of 15 patients were excluded because of the above criteria. In this cohort of 51 patients, 26 (51%) developed CRBSIs. Both groups were similar in terms of gestational age, diagnosis, nutrition status, and biochemical liver function tests. The mean (± standard deviation [SD]) minimum serum citrulline concentration was significantly lower in patients who developed CRBSIs (6.7 ± 4.6 µmol/L) than in those who did not (11.3 ± 6.4 µmol/L, P = .004). Multivariate logistic regression analysis identified lower minimum serum citrulline concentration and longer central venous catheter duration as independently associated with CRBSI (P = .003 and P = .038, respectively). CONCLUSIONS: Low serum citrulline concentration and longer central venous catheter time are independently associated with CRBSI in children with intestinal failure. Serum citrulline concentration may be a useful biomarker to identify patients with intestinal failure who are at high risk of developing a CRBSI.
BACKGROUND: Serum citrulline concentration is used as a biomarker of enterocyte mass and enteral tolerance, and low serum concentrations are correlated with bacteremia in immunosuppressed adults undergoing hematopoietic stem cell transplant. The authors sought to determine if citrulline was associated with the development of catheter-related bloodstream infections (CRBSIs) in children with intestinal failure. METHODS: Data were reviewed from 66 children treated in a multidisciplinary intestinal rehabilitation program, who had serum concentration citrulline measured between January 2007 and August 2009. All patients had a diagnosis of intestinal failure requiring parenteral nutrition (PN) support. Exclusion criteria included central venous catheter in situ <30 days, creatinine clearance <20 mL/minute, or a history of organ transplant/immunosuppression. RESULTS: A total of 15 patients were excluded because of the above criteria. In this cohort of 51 patients, 26 (51%) developed CRBSIs. Both groups were similar in terms of gestational age, diagnosis, nutrition status, and biochemical liver function tests. The mean (± standard deviation [SD]) minimum serum citrulline concentration was significantly lower in patients who developed CRBSIs (6.7 ± 4.6 µmol/L) than in those who did not (11.3 ± 6.4 µmol/L, P = .004). Multivariate logistic regression analysis identified lower minimum serum citrulline concentration and longer central venous catheter duration as independently associated with CRBSI (P = .003 and P = .038, respectively). CONCLUSIONS: Low serum citrulline concentration and longer central venous catheter time are independently associated with CRBSI in children with intestinal failure. Serum citrulline concentration may be a useful biomarker to identify patients with intestinal failure who are at high risk of developing a CRBSI.
Authors: Dick A van Waardenburg; Carlijn T de Betue; Yvette C Luiking; Monique Engel; Nicolaas E Deutz Journal: Am J Clin Nutr Date: 2007-11 Impact factor: 7.045
Authors: Igor Sukhotnik; Isaac Srugo; Jorge G Mogilner; Michael Lurie; Arnold G Coran; Ron Shaoul Journal: J Pediatr Gastroenterol Nutr Date: 2008-05 Impact factor: 2.839
Authors: Panagiotis Samaras; Stefan Dold; Julia Braun; Peter Kestenholz; Stefan Breitenstein; Alexander Imhof; Christoph Renner; Frank Stenner-Liewen; Bernhard C Pestalozzi Journal: Oncology Date: 2008-08-21 Impact factor: 2.935
Authors: Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan Journal: J Pediatr Gastroenterol Nutr Date: 2014-06 Impact factor: 2.839
Authors: Susan E Coffin; Sarah B Klieger; Christopher Duggan; W Charles Huskins; Aaron M Milstone; Gail Potter-Bynoe; Bram Raphael; Thomas J Sandora; Xiaoyan Song; Danielle M Zerr; Grace M Lee Journal: Infect Control Hosp Epidemiol Date: 2014-10-02 Impact factor: 3.254
Authors: Eric A Sparks; Faraz A Khan; Jeremy G Fisher; Brenna S Fullerton; Amber Hall; Bram P Raphael; Christopher Duggan; Biren P Modi; Tom Jaksic Journal: J Pediatr Surg Date: 2015-10-23 Impact factor: 2.545
Authors: Analee J Etheredge; Karim Manji; Mark Kellogg; Hao Tran; Enju Liu; Christine M McDonald; Rodrick Kisenge; Said Aboud; Wafaie Fawzi; David Bellinger; Andrew T Gewirtz; Christopher P Duggan Journal: J Pediatr Gastroenterol Nutr Date: 2018-06 Impact factor: 2.839
Authors: Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent Journal: Crit Care Date: 2020-06-05 Impact factor: 9.097